286 related articles for article (PubMed ID: 21689662)
1. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
[TBL] [Abstract][Full Text] [Related]
2. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
Rossetti G; Giachin G; Legname G; Carloni P
Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
4. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
5. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
6. Scrapie prions: a three-dimensional model of an infectious fragment.
Huang Z; Prusiner SB; Cohen FE
Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
[TBL] [Abstract][Full Text] [Related]
7. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics study of the dominant-negative E219K polymorphism in human prion protein.
Jahandideh S; Jamalan M; Faridounnia M
J Biomol Struct Dyn; 2015; 33(6):1315-25. PubMed ID: 25027605
[TBL] [Abstract][Full Text] [Related]
9. Prion propagation and molecular chaperones.
Zahn R
Q Rev Biophys; 1999 Nov; 32(4):309-70. PubMed ID: 11194568
[No Abstract] [Full Text] [Related]
10. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
[TBL] [Abstract][Full Text] [Related]
11. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
12. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
13. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
14. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
15. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
16. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
Avbelj M; Hafner-Bratkovič I; Jerala R
Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
[TBL] [Abstract][Full Text] [Related]
17. Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations.
Kuznetsov IB; Rackovsky S
Protein Sci; 2004 Dec; 13(12):3230-44. PubMed ID: 15557265
[TBL] [Abstract][Full Text] [Related]
18. Prion diseases. Yielding under the strain.
Weissmann C
Nature; 1995 Jun; 375(6533):628-9. PubMed ID: 7791890
[No Abstract] [Full Text] [Related]
19. Deadly conformations--protein misfolding in prion disease.
Horwich AL; Weissman JS
Cell; 1997 May; 89(4):499-510. PubMed ID: 9160742
[No Abstract] [Full Text] [Related]
20. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
